Should publicly held, early stage biotechs issue more shares or partner with Big Pharma?
With the right brand-value metrics and framework, managements can allocate marketing resources to improve both short- and long-term value creation.
Buyback ROI, a tool first introduced on CFO.com, can be used by executives and investors to determine when buybacks are more likely to be successful.
Performance metrics related to improvement or growth demonstrate the most positive relationships to shareholder return.
To drive shareholder returns in health care, CFOs should stress financial policies that build financial flexibility rather than leverage.
Companies should resist the urge to cut research expenses to meet an earnings per share target.
Although high debt levels are touted to be shareholder-friendly, highly levered companies do not deliver higher returns.